History of leukemia-lymphoma cell lines
Tóm tắt
We outline the near 50-year history of leukemia-lymphoma (LL) cell lines — a key model system in biomedicine. Due to the detailed documentation of their oncogenomic and transcriptional alterations via recent advances in molecular medicine, LL cell lines may be fitted to parent tumors with a degree of precision unattainable in other cancers. We have surveyed the corpus of published LL cell lines and found 637 examples that meet minimum standards of authentication and characterization. Alarmingly, the rate of establishment of new LL cell lines has plummeted over the last decade. Although the main hematopoietic developmental cell types are represented by cell lines, some LL categories stubbornly resist establishment in vitro. The advent of engineering techniques for immortalizing primary human cells that maintain differentiation means the time is ripe for renewed search for in vitro models from un(der)represented hematologic entities. Given their manifold applications in biomedicine, there is little doubt that LL-derived cell lines will continue to play a vital part well into the next half-century as well.
Tài liệu tham khảo
Harrison RG. Observations on the living developing nerve fiber. Proc Soc Exp Biol Med 1907; 4: 140–3.
Carrel A. On the permanent life of tissue outside of the organism. J Exp Med 1912; 15: 516–28.
Sanford KK, Earle WR, Likely GD. The growth in vitro of single isolated tissue cells. J Natl Cancer Inst 1948; 9: 229–46.
Landecker H. Culturing Life — How Cells Became Technologies. Cambridge, MA: Harvard University Press, 2007.
Gey GO, Coffman WD, Kubicek MT. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 1952; 12: 264–5.
Gold M. A Conspiracy of Cells. Albany, NY: State University of New York Press, 1986.
Pulvertaft RJV. Cytology of Burkitt’s tumour (African lymphoma). Lancet 1964; i: 238–40.
Osgood EE, Brooke JH. Continuous tissue culture of leukocytes from human leukemic bloods by application of gradient principles. Blood 1955; 10: 1010–22.
Nelson-Rees WA, Flandermeyer RR. HeLa cultures defined. Science 1976; 191: 96–8.
Drexler HG. Guide to Leukemia-lymphoma Cell Lines. Braunschweig: Compact Disc, 2010.
Drexler HG, Matsuo Y. Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia 1999; 13: 835–42.
MacLeod RAF, Drexler HG. Public repositories: users reluctant to give materials. Nature 2006; 439: 912.
Matsuo Y, Minowada J. Human leukemia cell lines. Clinical and theoretical significances. Hum Cell 1988; 1: 263–74.
Drexler HG, Gignac SM, Minowada J. Hematopoietic cell lines. In: Hay RJ, Gazdar R, Park JG, eds. Atlas of Human Tumor Cell Lines. Orlando, FL: Academic Press, 1994; 213–50.
Mire-Sluis AR, Page L, Thorpe R. Quantitative cell line based bioassays for human cytokine. J Immunol Methods 1995; 187: 191–9.
MacLeod RAF, Drexler HG. Cell lines are robust in vitro models. Br J Haematol 2008; 142: 137–8.
Drexler HG. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 1998; 12: 845–59.
Drexler HG, Fombonne S, Matsuo Y, Hu ZB, Hamaguchi H, Uphoff CC. p53 alterations in human leukemia-lymphoma cell lines: in vitro artifact or prerequisite for cell immortalization? Leukemia 2000; 14: 198–206.
Neve RM, Chin K, Fridlyand J et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006; 10: 515–27.
Sos ML, Michel K, Zander T et al. Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest 2009; 119: 1727–40.
Sharma SV, Haber DA, Settleman J. Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer 2010; 10: 241–53.
Rücker FG, Sander S, Döhner K, Döhner H, Pollack JR, Bullinger L. Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations. Leukemia 2006; 20: 994–1001.
Andersson A, Edén P, Lindgren D et al. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations. Leukemia 2005; 19: 1042–50.
Sandberg R, Ernberg I. Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci USA 2005; 102: 2052–7.
Bignell GR, Greenman CD, Davies H et al. Signatures of mutation and selection in the cancer genomes. Nature 2010; 463: 893–8.